<DOC>
	<DOC>NCT00741182</DOC>
	<brief_summary>The purpose of the study is to investigate, whether PTH(1-34) is able to promote fracture healing in postmenopausal women with fractures of the hip or shoulder.</brief_summary>
	<brief_title>Effect of PTH(1-34) Treatment on Fracture Healing in Vivo</brief_title>
	<detailed_description />
	<mesh_term>Fractures, Bone</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Shoulder Fractures</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Acute new osteoporotic trochanteric or collum chirurgicum fracture Postmenopause Calcium metabolic disease other than osteoporosis Diseases known to affect calcium homeostasis Dementia Hypersensitivity to drug or other components of medication preexisting hypercalcemia Decreased kidney function Increased alkaline phosphatase Prior external radiation therapy or brachytherapy of the skeleton Skeletal malignancies or bone metastases Alcohol and/or drug abuse Systemic treatment with corticosteroids within the last four weeks Noncooperating patients Patients who do not speak and understand the danish language</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Fracture</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>Forsteo</keyword>
	<keyword>Teriparatide</keyword>
	<keyword>Fracture healing</keyword>
</DOC>